Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases

Author： Rau Daniela   Lang Michael   Harth Andreas   Naumann Markus   Weber Frank   Tumani Hayrettin   Bayas Antonios  

Publisher： MDPI

E-ISSN： 1422-0067|16|7|14669-14676

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.16, Iss.7, 2015-06, pp. : 14669-14676

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond

By Ruck Tobias   Bittner Stefan   Wiendl Heinz   Meuth Sven G.  

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-07 ,pp. : 16414-16439

MDPI

Access to resources Recommend Favorite

Multiple Sclerosis: From Molecules to Treatment

By Broadley Simon A  

International Journal of Molecular Sciences, Vol. 14, Iss. 4, 2013-04 ,pp. : 7598-7602

MDPI

Access to resources Recommend Favorite

Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis

By Kolb-Mäurer Annette   Goebeler Matthias   Mäurer Mathias  

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-07 ,pp. : 14951-14960

MDPI

Access to resources Recommend Favorite

Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis

By Chiba Kenji   Adachi Kunitomo  

Pharmaceuticals, Vol. 5, Iss. 5, 2012-05 ,pp. : 514-528

MDPI

Access to resources Recommend Favorite

Multiple Sclerosis and Schizophrenia

By Arneth Borros M.  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-08 ,pp. : 1760-1760

MDPI

Access to resources Recommend Favorite